BOCA RATON, Fla.--(BUSINESS WIRE)--Nov. 11, 2015--
TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women’s healthcare
company, today announced Chief Executive Officer Robert G. Finizio will
provide an overview of the company at the Stifel 2015 Healthcare
Conference on November 17th at The New York Palace Hotel in
New York. The presentation is scheduled to begin at 10:15 a.m. EST.
Details for the presentation and webcast are:
Shortly after completion of the webcast, replays will be available for
at least 30 days on the company's website, www.therapeuticsmd.com,
in the “Investor” section.
About TherapeuticsMD, Inc.
TherapeuticsMD, Inc. is an innovative healthcare company focused on
developing and commercializing products exclusively for women. With its
SYMBODA™ technology, TherapeuticsMD is developing advanced hormone
therapy pharmaceutical products to enable delivery of bio-identical
hormones through a variety of dosage forms and administration routes.
The company’s clinical development pipeline includes two phase 3
products. The company also manufactures and distributes branded and
generic prescription prenatal vitamins as well as over-the-counter
vitamins under the vitaMedMD® and BocaGreenMD®
brands. More information is available at the following websites: www.therapeuticsmd.com,
View source version on businesswire.com: http://www.businesswire.com/news/home/20151111005097/en/
Source: TherapeuticsMD, Inc.
Dan Cartwright, 561-961-1900